The Daily Brief

November 06, 2026

San Antonio's city council is moving forward with a comprehensive economic analysis of marijuana legalization just days after Texas voters shifted the state toward Democratic control. Half of the city's council members—led by District 2 Councilman Jalen McKee-Rodriguez—submitted a formal proposal Thursday requesting a detailed study of how legal cannabis could impact job creation, tax revenue, and business development across the city and state. The timing is strategic: McKee-Rodriguez explicitly hopes the findings will be ready before the Texas Legislature reconvenes in January, giving lawmakers localized economic data as they consider policy changes under new Lieutenant Governor-elect Vikki Goodwin, who has publicly supported reforms to the state's marijuana and hemp policies. "Money The analysis will examine major U.S. cities where regulated cannabis markets are already operational, evaluating employment figures, government revenue streams, and potential business opportunities," with the goal of answering constituent questions about why Texas hasn't pursued legalization as an economic driver.

Meanwhile, across the country, the political landscape for cannabis access is rapidly evolving in multiple directions. Massachusetts' Senate advanced a bill Thursday that would allow military veterans to obtain state medical marijuana cards without requiring a doctor's recommendation—a critical workaround to federal VA restrictions that currently prevent VA physicians from filling out cannabis certification forms. Notable The legislation recognizes that many veterans have been forced to seek expensive outside consultants or forgo legal access entirely, and it expands qualifying conditions to include PTSD, opioid use disorder, and chronic pain. Kentucky announced a significant milestone in program implementation: the state's medical marijuana program now has over 30,000 registered cardholders and 27 operational dispensaries, with 47 of 80 approved businesses already operational across all 11 licensing regions. Lieutenant Governor Jacqueline Coleman celebrated the expansion, noting that more than 500 approved medical practitioners are now recommending cannabis to patients suffering from conditions like cancer, PTSD, and multiple sclerosis.

In Wisconsin, three Republican state legislators introduced a bill to legalize medical marijuana, marking a notable shift in a state where GOP leadership had previously blocked legalization efforts in the governor's budget. Senate President Mary Felzkowski, Sen. Patrick Testin, and Rep. Patrick Snyder are backing legislation that would create a full regulatory framework for growers, processors, labs, and dispensaries while including safeguards against misuse. Testin told reporters that the bill represents "good common ground" where private industry can participate, creating jobs and employment opportunities while providing patients access to relief. "Context Medical marijuana is now legal in at least 40 other states, and momentum has shifted within the Republican caucus as both parties recognize the bipartisan appeal of the issue."

At the federal level, Representative Dina Titus, co-chair of the Congressional Cannabis Caucus, signaled willingness to work with the Trump administration on marijuana descheduling, though she stopped short of endorsing a "clean" descheduling bill stripped of social equity provisions. Reports indicate that a senior Trump adviser stated the president would sign straightforward descheduling legislation while likely vetoing broader packages like the MORE Act that include expungement and community reinvestment programs. Titus emphasized commitment to finding "a bipartisan solution with my colleagues in Congress and with the current Administration," but her statement left open the tension between advocates pushing for comprehensive reform versus those prioritizing removal from the Controlled Substances Act alone.

In Texas cities, implementation questions remain as Houston voters approved Proposition A—directing the Houston Police Department to make low-level marijuana possession its "lowest possible enforcement priority"—yet the police union says officers have received no specific guidance on enforcement protocols. The Harris County District Attorney's Office stated it has not issued additional guidance and continues to urge the Texas Legislature to clarify cannabis laws. Money The DA's office reports that marijuana possession accounts for just 0.021% of misdemeanor charges it accepts, while jail populations continue to decrease as prosecutors focus resources on violent offenders and drug traffickers. Finally, the U.S. Court of Appeals for the Armed Forces scheduled oral arguments for November 19 in a case challenging the military's longstanding "permissive inference" rule—which allows judges to infer knowing marijuana use based solely on a positive urinalysis, even without direct evidence of intentional consumption. The case centers on whether widespread cannabis legalization and the proliferation of THC-containing products have fundamentally changed the legal landscape under which that 1987 inference was established.

November 06, 2026

Canopy Growth Corporation is charging ahead internationally, reporting CA$81.4 million in quarterly net revenue—a 22% year-over-year increase—with international marijuana sales exploding 141% as the company expands aggressively into European medical markets. Money The surge was driven primarily by rising medical marijuana sales in Germany and Poland, while Canadian medical marijuana revenue climbed 18% to CA$25.8 million and recreational sales increased 17% to CA$28.1 million. Canopy's Smiths Falls facility earned European Union Good Manufacturing Practice certification during the quarter, clearing the way for expanded international manufacturing and distribution. Despite the revenue growth, the company reported a net loss of CA$40.7 million for the quarter—largely due to CA$35.8 million in fair-value charges tied to its Canopy USA assets—though its adjusted EBITDA loss narrowed to CA$2.9 million, a 6% improvement from the prior year.

TerrAscend, meanwhile, reported $68.2 million in quarterly revenue, up 4.8% year-over-year, while extending its streak of positive operating cash flow to 17 consecutive quarters—a rare feat of financial stability in a capital-intensive industry. Money The company generated $8.8 million in operating cash flow during the quarter and achieved $6.1 million in free cash flow, marking its 13th straight quarter in the black. Pennsylvania drove particularly strong performance, with same-store retail sales jumping 12% and wholesale revenue climbing 31%, while TerrAscend also completed its acquisition of Aunt Mary's dispensary in New Jersey—a location generating over $10 million in annualized revenue. The company ended September with $42.5 million in cash and moved forward on preparations for a potential listing on a major U.S. stock exchange after shareholders approved a share consolidation in August.

On the regulatory front, Missouri took aggressive action to enforce restrictions on intoxicating hemp products. A federal judge dismissed a legal challenge to House Bill 2641 on November 4, clearing the way for key provisions to take effect November 12—just days later, the state's attorney general announced lawsuits against four retailers accused of illegally marketing marijuana products as federally legal hemp while posing as licensed dispensaries. The dismissed challenge had been filed by the MoHemp Trade Association, Lifted Liquids, and MNG 2005, which argued the law was unconstitutionally vague and conflicted with federal hemp protections. Context The litigation reflects ongoing tension between state-level cannabis regulation and the current federal hemp framework—a pattern repeating across multiple states as intoxicating hemp products occupy legal gray zones.

Georgia's medical marijuana program continued its expansion with six new dispensary licenses issued November 4, bringing the statewide total to 28 active licenses. Trulieve received two additional Atlanta-area locations, expanding from seven to nine licenses in Georgia, while True Bliss Dispensary operator TheraTrue Georgia received four new licenses in Atlanta, Fayetteville, Marietta, and Buford, bringing its total to eight. Notable The 27.3% single-day increase in licensed locations reflects the program's accelerating growth as Georgia's patient registry approaches 65,000—the state's medical marijuana program has expanded substantially since the Putting Georgia's Patients First Act took effect July 1, with the law broadening qualifying conditions and permitting flower and concentrated products while maintaining the state's prohibition on smoking. Another dispensary application window opens November 16 through November 20, with additional licenses likely to follow as patient enrollment continues climbing.

Illinois cannabis workers at Zen Leaf Dispensary voted to decertify the UFCW union, removing union representation from the workplace in a significant labor development for the state's cannabis sector. Meanwhile, Verano expanded its footprint to 87 Florida dispensaries with a new MÜV retail facility opening in Fernandina Beach, pushing the company's nationwide store count to 164 locations. Both stories underscore the maturing infrastructure of the legal cannabis market—companies are scaling retail networks, establishing stable operations, and beginning to navigate employment and labor dynamics typical of mainstream industries. Money These expansions represent capital deployment and market consolidation by operators positioned to capture medical marijuana demand in states with active patient bases and regulatory clarity.

November 06, 2026

Archaeological evidence pushes back the timeline of ceremonial cannabis use by 300 years. Researchers at the University of Bern identified over 1,000 preserved cannabis seeds and detectable cannabinoid compounds in human hair at a 2,800-year-old burial site in Siberia, according to a study published this week in Science. The findings predate written accounts by Greek historian Herodotus, who described Scythian purification ceremonies involving cannabis smoke—evidence that the plant held cultural significance in ancient Eurasian societies millennia before European contact.

Meanwhile, the federal hemp regulatory landscape fractured along starkly different lines following this week's election results. Illinois Governor JB Pritzker, Lieutenant Governor Juliana Stratton, and Senator Tammy Duckworth released a policy agenda calling on Congress to let a planned federal ban on intoxicating hemp products take effect without delay on December 11. Their push contradicts developments in Texas, where Lt. Governor Dan Patrick's crusade against hemp-derived THC products cost him his re-election bid. Vikki Goodwin, an Austin state representative who centered her campaign on undoing restrictions on hemp-derived products and directing tax revenue toward health insurance for low-income Texans, defeated Patrick—a close Trump ally—in a race that hemp industry leaders are framing as a referendum on cannabis access.

Money The business consequences are already visible on the ground. Hemp retailers in North Carolina and Illinois are closing ahead of the December deadline, while manufacturers like Hometown Hero are bracing for significant market disruption. The industry faces a genuine split: some states moving toward regulation and revenue, others toward recriminalization. Context The December 11 effective date creates a narrow window for lawmakers to establish federal hemp product regulations, but Illinois officials are openly opposing delay—suggesting the legislative path forward remains deeply contested despite Democratic control of Congress.

Shayda Torabi, co-founder of RESTART CBD in Austin, cautioned that Texas's election results, while favorable to hemp advocates, do not automatically resolve years of regulatory whiplash. Smokeable hemp products in Texas have moved "back and forth through agency rules and court orders," she noted, and the new federal total THC test taking effect December 11 will eliminate THCA flower—the raw, unheated version of THC—from the legal market regardless of state-level changes. The practical consequence: Texas consumers could face months without access to certain products even if lawmakers act quickly to legalize them. Industry observers across states now face an uncertain regulatory environment that turns on whether Congress permits the ban to take effect, delays it further, or establishes clear federal standards for hemp-derived products before the deadline arrives.

November 06, 2026

Recent research is raising fresh questions about cannabis and cardiovascular health, even as landmark policy shifts unfold internationally and new neuroscience reveals surprises about how the plant affects different populations.

A major study of nearly 450,000 American adults, set for presentation at the American Heart Association's Scientific Sessions this week in Chicago, found that both casual and heavy marijuana users report higher odds of cardiovascular disease compared to non-users. The findings, drawn from CDC surveillance data collected between 2020 and 2024, show that occasional users—those consuming cannabis just one to five days per month—reported 40% higher odds of a previous stroke, while those using 16 to 30 days per month had 21% higher odds. Heavy users reported 25% higher odds. Context The counterintuitive pattern—where lighter use showed stronger stroke associations than heavier use—defies straightforward dose-response logic, prompting researchers to note the relationship may be more complex than initial assumptions suggested. The study found no statistically significant link between cannabis use and heart attacks, and consumption method—smoking, vaping, or edibles—did not change the outcome. Dr. Kristen Worth, a physician and medical adviser at telehealth platform NuggMD, cautioned against interpreting the nonlinear pattern as evidence that heavier use is safer, calling the overall findings "particularly interesting" for stroke risk specifically.

Meanwhile, Money Nepal's Supreme Court has ordered the government to establish regulatory frameworks for cannabis cultivation and production for medical, scientific, and industrial purposes within three months, after finding authorities had failed for nearly half a century to implement existing legal obligations. The ruling, which stems from a petition by attorney Saroj Adhikari seeking a review of cannabis restrictions, also urges authorities to explore possible reforms to the country's recreational prohibition—a significant symbolic moment for a nation that became synonymous with cannabis culture during the 1960s Hippie Trail era, before tightening laws in 1976 amid international pressure. The court's decision carries historical weight in a country where cannabis was legal and sold under government licenses in the 1960s and has been used medicinally and religiously for generations.

Notable Separate research presented this week challenges assumptions about cannabis effects across populations: a study examining occasional cannabis users found that men reported feeling stronger effects than women, suggesting biological or physiological sex differences in how the plant is experienced. Additionally, archaeological evidence from a Siberian burial site reveals that cannabis was used as an intoxicant 2,800 years ago by Scythian nomads, extending the documented history of intentional cannabis consumption far beyond previously known records and demonstrating the plant's long role in human societies across continents and millennia.

On the policy front in the United States, a San Antonio city councilman has called for a cannabis legalization study as Texas continues its ongoing THC debate, reflecting momentum in a state where the political landscape shifted notably in the recent election cycle. These developments arrive amid accelerating state-level normalization and growing recognition that cannabis science—its cardiovascular profile, genetic interactions, archaeological history, and regulatory potential—demands serious, evidence-based examination rather than reflexive prohibition or equally reflexive celebration.